IP Library Granted Patent US 8,237,007
Granted Patent B2
US 8,237,007 · App. 11/972,452 · Granted Aug 7, 2012

Wound dressing with controllable permeability

Assignee: PolyRemedy, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,237,007
App. No.
11/972,452
Granted
Aug 7, 2012
Kind
B2
Abstract

Wound dressings and methods of manufacturing wound dressings are provided. The wound dressings include portions that are converted from a moisture vapor permeable material to a material having reduced moisture vapor permeability. The conversion may be accomplished in a variety of ways. In some embodiments, a solvent is used to dissolve a porous material to thereby form a non-porous film. In other embodiments, heat is applied to melt a porous material to thereby form a non-porous film. The heat may be applied using a heated gas or a heating element to directly or indirectly heat the material.

Claims (35)

1. A wound dressing comprising:

a first layer having a first region characterized by a respective first moisture vapor transmission rate (MVTR 1 ) and having a second region characterized by a respective second and smaller moisture vapor transmission rate (MVTR 2 ), wherein said first and second regions are shaped and sized to match corresponding regions of the wound;

a second layer disposed adjacent the first layer, said second layer having a higher melting point than the first layer; and

a third layer provided above the first layer so that the first layer is sandwiched between the third layer and the second layer, said third layer having a higher melting point than the first layer, where the second and third layers are porous and the third layer has a larger average pore size than that of the second layer.

2. The wound dressing of claim 1 , wherein:

the third layer comprises hydrophobic polymer microfibers.

3. The wound dressing of claim 2 , wherein:

the first layer, the second layer, or the third layer includes a substance enhancing wound healing.

4. The wound dressing of claim 2 , wherein:

the first layer, the second layer, or the third layer includes a pharmacological substance.

5. The wound dressing of claim 1 , wherein:

at least one of the first and second layers comprises hydrophobic polymer microfibers.

6. The wound dressing of claim 1 , wherein:

at least one of the first layer and the second layer has bacteriostatic, bactericidal, or antifungal properties.

7. A wound dressing comprising:

a first layer having a first region characterized by a respective first moisture vapor transmission rate (MVTR 1 ) and having a second region characterized by a respective second and smaller moisture vapor transmission rate (MVTR 2 ), wherein said first and second regions are shaped and sized to match corresponding regions of the wound; and

a second layer disposed adjacent the first layer, said second layer having a higher melting point than the first layer, wherein said second layer comprising a material insoluble in the first solvent and the first layer comprises a first microfiber type and a second micro fiber type, said first microfiber type being soluble in a first solvent and the second microfiber type being insoluble in the first solvent.

8. The wound dressing of claim 7 , wherein:

the second layer comprises hydrophobic polymer microfibers.

9. A dressing for assisting in healing of a wound to skin of a patient where the wound may have different wound attributes in respective one or more regions of the wound, the dressing comprising:

a first sheet, said first sheet having a first layer generally characterized by a respective first moisture vapor transmission rate (MVTR 1 ) greater than 0.05 g/sq·cm/24 hour and having a second layer characterized by a respective melting point that is smaller than that of the first layer; and

a second sheet comprising a third layer and a fourth layer, wherein the third layer generally characterized by a respective second moisture vapor transmission rate (MVTR 2 ) greater than 0.05 g/sq·cm/24 hour and wherein the fourth layer is characterized by a respective melting point that is smaller than that of the third layer;

wherein the second layer of the first sheet is bonded to the third layer of the second sheet by a melted and resolidified portion of the second layer.

10. The dressing of claim 9 , wherein:

a portion of the fourth layer of the second sheet is a selectively converted portion which is locally characterized by a respective third moisture vapor transmission rate (MVTR 3 ) that is smaller than the general first moisture vapor transmission rate (MVTR 1 ) of the first sheet.

11. The dressing of claim 9 , wherein:

a lateral dimension of the second sheet is larger than a lateral dimension of the first sheet.

12. The dressing of claim 9 , wherein:

the first sheet comprises a first layer and a second layer, wherein the second layer of the first sheet has a lower melting point than the first layer of the first sheet and is bonded to the second layer of the second sheet.

13. The dressing of claim 12 , further comprising:

a third sheet comprising a first layer and a second layer, wherein the second layer of the third sheet has a lower melting point than the first layer of the third sheet and is bonded to the first layer of the first sheet.

14. The dressing of claim 13 , wherein:

a lateral dimension of the third sheet is larger than a lateral dimension of the first sheet.

15. The dressing of claim 13 , wherein:

a lateral dimension of the second sheet is larger than a lateral dimension of the first sheet and a lateral dimension of the third sheet.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Oct 14, 2016
From: ADVANCED TECHNOLOGY VENTURES VIII, L.P.; FLYBRIDGE CAPITAL PARTNERS II, L.P.; MEDVENTURE ASSOCIATES V, L.P.; MICHAEL MURRAY TRADING PARTNERS, L.P.; BARRETT, KEVIN
To: NUVESSE SKIN THERAPIES, INC.
Reel/Frame 040024/0139 →
CHANGE OF NAME Recorded Oct 7, 2016
From: POLYREMEDY, INC.
To: NUVESSE SKIN THERAPIES, INC.
Reel/Frame 039969/0276 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ADDRESS OF ASSIGNEE: KEVIN BARRETT PREVIOUSLY RECORDED ON REEL 038832 FRAME 0047. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT OF ASSIGNORS INTEREST. Recorded Jun 8, 2016
From: POLYREMEDY, INC.
To: ADVANCED TECHNOLOGY VENTURES VIII, L.P.; FLYBRIDGE CAPITAL PARTNERS II, L.P.; MEDVENTURE ASSOCIATES V, L.P.; KEVIN BARRETT; MICHAEL MURRAY TRADING PARTNERS, L.P.
Reel/Frame 038925/0748 →
SECURITY AGREEMENT Recorded May 27, 2016
From: POLYREMEDY, INC.
To: ADVANCED TECHNOLOGY VENTURES VIII, L.P.; FLYBRIDGE CAPITAL PARTNERS II, L.P.; MEDVENTURE ASSOCIATES V, L.P.; BARRETT, KEVIN; MICHAEL MURRAY TRADING PARTNERS, L.P.
Reel/Frame 038832/0047 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 10, 2008
From: SINIAGUINE, OLEG
To: POLYREMEDY, INC.
Reel/Frame 020349/0995 →
Continuity (3)
Provisional Application 60884321 · Jan 10, 2007
Provisional Application 60888693 · Feb 7, 2007
Related Publication 20080167594A1 · Jul 10, 2008